InvestorsHub Logo
Followers 138
Posts 23723
Boards Moderated 0
Alias Born 04/08/2004

Re: Investor2014 post# 456495

Friday, 04/12/2024 3:39:41 PM

Friday, April 12, 2024 3:39:41 PM

Post# of 469996
investor, you are lying.

Dr. A. Barrie Pittock as I said stated previously the Phase 2b/3 trial in 2018.

https://www.anavex.com/press-releases/anavex-life-sciences-presents-new-three-year%2C-longitudinal-clinical-efficacy-data-for-anavex®2-73-in-alzheimer’s-disease-at-the-2018-clinical-trials-on-alzheimer’s-disease-(ctad)-meeting

"...Christopher U Missling, Ph.D., President and Chief Executive Officer of Anavex. “We continue to build on the body of clinical evidence to support the development of ANAVEX®2-73 as we further our recently initiated Phase 2b/3 study, and we will continue our targeted precision medicine approach to advance ANAVEX®2-73 as a potential therapeutic option for patients with Alzheimer’s disease who will most benefit from treatment.”...."



GOD bless,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News